Abnova produce y desarrolla mas de 19.000 proteínas recombinantes, mas de 12.000 anticuerpos MaxPab, mas de 16.000 anticuerpos monoclonales y mas de 20.000 anticuerpos policlonales dirigidos al genoma humano.
VHH-His tag NanoAb™ Targeting Human PCSK9, clone 3076
VHH-His tag NanoAb™ Targeting Human PCSK9, clone 3076 (FITC)
VHH-His tag NanoAb™ Targeting Human RSV, clone UA01
VHH-His tag NanoAb™ Targeting Human RSV, clone UA01 (FITC)
VHH-His tag NanoAb™ Targeting Human SOST, clone 1080
VHH-His tag NanoAb™ Targeting Human SOST, clone 1080 (FITC)
VHH-His tag NanoAb™ Targeting Human TREM2, clone 3038
VHH-His tag NanoAb™ Targeting Human TREM2, clone 3038 (FITC)
VHH-His tag NanoAb™ Targeting Human VEGFR2, clone 4082
VHH-His tag NanoAb™ Targeting Human VEGFR2, clone 4082 (FITC)
VHH-His tag NanoAb™ Targeting Human Varicella zoster virus gE, clone I032
VHH-His tag NanoAb™ Targeting Human Varicella zoster virus gE, clone I032 (FITC)